A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients
Gespeichert in:
Verfasser / Beitragende:
[C A Jansen, H C van Os, H J Out, H J Coelingh Bennink]
Ort, Verlag, Jahr:
1998
Enthalten in:
Human reproduction (Oxford, England), 13/11(1998-11), 2995-2999
Format:
Artikel (online)
Online Zugang: